227 related articles for article (PubMed ID: 28747392)
21. Comparison of outcomes for patients with lepidic pulmonary adenocarcinoma defined by 2 staging systems: A North American experience.
Wilshire CL; Louie BE; Horton MP; Castiglioni M; Aye RW; Farivar AS; West HL; Gorden JA; Vallières E
J Thorac Cardiovasc Surg; 2016 Jun; 151(6):1561-8. PubMed ID: 26897242
[TBL] [Abstract][Full Text] [Related]
22. Prognostic impact of lung adenocarcinoma second predominant pattern from a large European database.
Bertoglio P; Querzoli G; Ventura L; Aprile V; Cattoni MA; Nachira D; Lococo F; Rodriguez Perez M; Guerrera F; Minervini F; Gnetti L; Bacchin D; Franzi F; Rindi G; Bellafiore S; Femia F; Viti A; Bogina GS; Kestenholz P; Ruffini E; Paci M; Margaritora S; Imperatori AS; Lucchi M; Ampollini L; Terzi AC
J Surg Oncol; 2021 Feb; 123(2):560-569. PubMed ID: 33169397
[TBL] [Abstract][Full Text] [Related]
23. Significant difference in recurrence according to the proportion of high grade patterns in stage IA lung adenocarcinoma.
Jeon HW; Kim YD; Sim SB; Moon MH
Thorac Cancer; 2021 Jul; 12(13):1952-1958. PubMed ID: 34037324
[TBL] [Abstract][Full Text] [Related]
24. Mitosis trumps T stage and proposed international association for the study of lung cancer/american thoracic society/european respiratory society classification for prognostic value in resected stage 1 lung adenocarcinoma.
Duhig EE; Dettrick A; Godbolt DB; Pauli J; van Zwieten A; Hansen AR; Yang IA; Fong KM; Clarke BE; Bowman RV
J Thorac Oncol; 2015 Apr; 10(4):673-81. PubMed ID: 25514800
[TBL] [Abstract][Full Text] [Related]
25. Prognostic histologic subtyping of dominant tumor in resected synchronous multiple adenocarcinomas of lung.
Tsai PC; Liu C; Yeh YC; Chen CK; Hsu PK; Chen HS; Huang CS; Hsieh CC; Hsu HS; Huang BS
Sci Rep; 2021 May; 11(1):9539. PubMed ID: 33953254
[TBL] [Abstract][Full Text] [Related]
26. Relationship between lung adenocarcinoma histological subtype and patient prognosis.
Urer HN; Kocaturk CI; Gunluoglu MZ; Arda N; Bedirhan MA; Fener N; Dincer SI
Ann Thorac Cardiovasc Surg; 2014; 20(1):12-8. PubMed ID: 23364232
[TBL] [Abstract][Full Text] [Related]
27. Prognostic value of the new IASLC/ATS/ERS classification of clinical stage IA lung adenocarcinoma.
Murakami S; Ito H; Tsubokawa N; Mimae T; Sasada S; Yoshiya T; Miyata Y; Yokose T; Okada M; Nakayama H
Lung Cancer; 2015 Nov; 90(2):199-204. PubMed ID: 26341957
[TBL] [Abstract][Full Text] [Related]
28. Why do pathological stage IA lung adenocarcinomas vary from prognosis?: a clinicopathologic study of 176 patients with pathological stage IA lung adenocarcinoma based on the IASLC/ATS/ERS classification.
Zhang J; Wu J; Tan Q; Zhu L; Gao W
J Thorac Oncol; 2013 Sep; 8(9):1196-202. PubMed ID: 23945388
[TBL] [Abstract][Full Text] [Related]
29. A comprehensive evaluation of clinicopathologic characteristics, molecular features and prognosis in lung adenocarcinoma with solid component.
Li J; You W; Zheng D; Yan B; Ma X; Pan Y; Zhang Y; Li Y; Shen X; Cheng X; Sun Y; Chen H
J Cancer Res Clin Oncol; 2018 Apr; 144(4):725-734. PubMed ID: 29368062
[TBL] [Abstract][Full Text] [Related]
30. Risk factors of recurrence for resected T1aN0M0 invasive lung adenocarcinoma: a clinicopathologic study of 177 patients.
Yang F; Chen K; Liao Y; Li X; Sun K; Bao D; Wang J
World J Surg Oncol; 2014 Sep; 12():285. PubMed ID: 25216551
[TBL] [Abstract][Full Text] [Related]
31. BRMS1 Expression in Surgically Resected Lung Adenocarcinoma Predicts Future Metastases and Is Associated with a Poor Prognosis.
Bucciarelli PR; Tan KS; Chudgar NP; Brandt W; Montecalvo J; Eguchi T; Liu Y; Aly R; Travis WD; Adusumilli PS; Jones DR
J Thorac Oncol; 2018 Jan; 13(1):73-84. PubMed ID: 29097253
[TBL] [Abstract][Full Text] [Related]
32. Extracapsular extension is a powerful prognostic factor in stage IIA-IIIA non-small cell lung cancer patients with completely resection.
Liu W; Shao Y; Guan B; Hao J; Cheng X; Ji K; Wang K
Int J Clin Exp Pathol; 2015; 8(9):11268-77. PubMed ID: 26617851
[TBL] [Abstract][Full Text] [Related]
33. Prognostic significance of predominant histologic pattern and nuclear grade in resected adenocarcinoma of the lung: potential parameters for a grading system.
von der Thüsen JH; Tham YS; Pattenden H; Rice A; Dusmet M; Lim E; Nicholson AG
J Thorac Oncol; 2013 Jan; 8(1):37-44. PubMed ID: 23242436
[TBL] [Abstract][Full Text] [Related]
34. Oncologic outcomes of segmentectomy compared with lobectomy for clinical stage IA lung adenocarcinoma: propensity score-matched analysis in a multicenter study.
Tsutani Y; Miyata Y; Nakayama H; Okumura S; Adachi S; Yoshimura M; Okada M
J Thorac Cardiovasc Surg; 2013 Aug; 146(2):358-64. PubMed ID: 23477694
[TBL] [Abstract][Full Text] [Related]
35. Adenocarcinoma predominant pattern subtyping and nuclear grading in cytology: Is there a role in prognostication of advanced pulmonary adenocarcinomas?
Nambirajan A; Kaur H; Jangra K; Kaur K; Madan K; Mathur SR; Iyer VK; Jain D
Cytopathology; 2018 Apr; 29(2):163-171. PubMed ID: 29388266
[TBL] [Abstract][Full Text] [Related]
36. Predictive value of the international association for the study of lung cancer/American Thoracic Society/European Respiratory Society classification of lung adenocarcinoma in tumor recurrence and patient survival.
Hung JJ; Yeh YC; Jeng WJ; Wu KJ; Huang BS; Wu YC; Chou TY; Hsu WH
J Clin Oncol; 2014 Aug; 32(22):2357-64. PubMed ID: 24799473
[TBL] [Abstract][Full Text] [Related]
37. Radiologic findings to predict low-grade malignant tumour among clinical T1bN0 lung adenocarcinomas: lessons from histological subtypes.
Mimae T; Miyata Y; Mimura T; Ito H; Nakayama H; Okumura S; Yoshimura M; Okada M
Jpn J Clin Oncol; 2015 Aug; 45(8):767-73. PubMed ID: 26056324
[TBL] [Abstract][Full Text] [Related]
38. A grading system of lung adenocarcinomas based on histologic pattern is predictive of disease recurrence in stage I tumors.
Sica G; Yoshizawa A; Sima CS; Azzoli CG; Downey RJ; Rusch VW; Travis WD; Moreira AL
Am J Surg Pathol; 2010 Aug; 34(8):1155-62. PubMed ID: 20551825
[TBL] [Abstract][Full Text] [Related]
39. The prognostic role of pathologic invasive component size, excluding lepidic growth, in stage I lung adenocarcinoma.
Tsutani Y; Miyata Y; Mimae T; Kushitani K; Takeshima Y; Yoshimura M; Okada M
J Thorac Cardiovasc Surg; 2013 Sep; 146(3):580-5. PubMed ID: 23778085
[TBL] [Abstract][Full Text] [Related]
40. Prognostic impact of GATA binding protein-3 expression in primary lung adenocarcinoma.
Hashiguchi T; Miyoshi H; Nakashima K; Yokoyama S; Matsumoto R; Murakami D; Mitsuoka M; Takamori S; Akagi Y; Ohshima K
Hum Pathol; 2017 May; 63():157-164. PubMed ID: 28322854
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
